The estimated Net Worth of Kevin Dennis Green is at least $3.75 Milion dollars as of 3 September 2024. Mr. Green owns over 82,657 units of Cerus stock worth over $1,098,991 and over the last 16 years he sold CERS stock worth over $1,399,714. In addition, he makes $1,249,930 as Chief Financial Officer a Vice President - Finance at Cerus.
Kevin has made over 21 trades of the Cerus stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 82,657 units of CERS stock worth $178,539 on 3 September 2024.
The largest trade he's ever made was selling 95,741 units of Cerus stock on 3 November 2021 worth over $670,187. On average, Kevin trades about 19,094 units every 67 days since 2009. As of 3 September 2024 he still owns at least 536,093 units of Cerus stock.
You can see the complete history of Mr. Green stock trades at the bottom of the page.
Kevin Dennis Green CPA serves as Chief Financial Officer, Vice President - Finance of the Company. Prior to that, Mr. Green served as our Vice President, Finance and Chief Accounting Officer, a role to which he was appointed in March 2009. From January 2006 to March 2009, Mr. Green was our Senior Director of Finance and Controller. From 2000 until 2006, Mr. Green held various financial management positions with Macromedia, Inc., a software company acquired by Adobe Systems in 2005, including Director of Finance and Assistant Controller. Prior to joining Macromedia, Mr. Green was a member of PricewaterhouseCoopers LLP in the Assurance and Business Advisory Services division. Mr. Green is a certified public accountant. Mr. Green received his BS in Accounting from California State University, Fresno.
As the Chief Financial Officer a Vice President - Finance of Cerus, the total compensation of Kevin Green at Cerus is $1,249,930. There are 4 executives at Cerus getting paid more, with William Greenman having the highest compensation of $3,270,180.
Kevin Green is 48, he's been the Chief Financial Officer a Vice President - Finance of Cerus since 2013. There are 12 older and 1 younger executives at Cerus. The oldest executive at Cerus Corp. is Laurence Corash, 76, who is the Chief Scientific Officer.
Kevin's mailing address filed with the SEC is C/O CERUS CORPORATION, 1220 CONCORD AVE SUITE 600, CONCORD, CA, 94520.
Over the last 21 years, insiders at Cerus have traded over $5,083,598 worth of Cerus stock and bought 1,382,745 units worth $4,903,526 . The most active insiders traders include William Mariner Greenman, Laurence M Corash a Bruce C Cozadd. On average, Cerus executives and independent directors trade stock every 33 days with the average trade being worth of $90,805. The most recent stock trade was executed by Kevin Dennis Green on 3 September 2024, trading 82,657 units of CERS stock currently worth $178,539.
cerus corporation is a biomedical products company focused on commercializing the intercept blood system to enhance blood safety. the intercept system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. the nucleic acid targeting mechanism of action enables intercept treatment to inactivate established transfusion threats, such as hepatitis b and c, hiv, west nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. cerus currently markets and sells the intercept blood system for both platelets and plasma in europe, russia, the middle east and selected countries in other regions around the world. the intercept red blood cell system is in clinical development.
Cerus executives and other stock owners filed with the SEC include: